Related Experiment Videos
Acquired angio-oedema caused by IgA paraprotein
D J van Spronsen1, S J Hoorntje, A J Hannema
1Department of Internal Medicine, Catharina Hospital, Eindhoven, Netherlands. d.j.van.spronsen@int.azg.nl
The Netherlands Journal of Medicine
|May 9, 1998
Summary
Acquired angio-oedema can stem from C1-inhibitor (C1-INH) deficiency, often linked to B-cell cancers. This case highlights rare IgA antibodies inactivating C1-INH, causing recurrent symptoms.
Area of Science:
- Immunology
- Complement System Biology
- Hematology
Background:
- Acquired angio-oedema is a rare condition characterized by recurrent swelling and abdominal pain, often associated with acquired C1-inhibitor deficiency.
- Acquired C1-inhibitor deficiency is typically linked to B-cell malignancies, affecting approximately 50 reported patients.
- The complement system's regulatory pathways are crucial for preventing uncontrolled inflammation.
Observation:
- A patient presented with an 8-year history of recurrent abdominal pain and angio-oedema.
- The patient was diagnosed with acquired C1-inhibitor deficiency.
- Bone marrow analysis revealed an IgA-kappa monoclonal plasma cell population without overt myeloma.
Findings:
- The patient's acquired C1-inhibitor deficiency was caused by IgA-kappa autoantibodies that inactivate C1-inhibitor.
- This represents an extremely rare mechanism for angio-oedema, particularly an IgA isotype autoantibody.
- This is the first reported case of such a condition in a Dutch patient.
Implications:
- Accurate diagnosis of angio-oedema, including rare acquired forms, is critical due to significant therapeutic implications.
- Understanding autoantibody-mediated complement dysregulation expands knowledge of angio-oedema pathogenesis.
- This case underscores the importance of investigating atypical presentations of angio-oedema and C1-INH deficiency.